India · Delayed Price · Currency is INR Blueprint Medicines Statistics
Total Valuation
NSE:GRSE has a market cap or net worth of INR 300.65 billion. The enterprise value is 263.43 billion.
| Market Cap | 300.65B |
| Enterprise Value | 263.43B |
Important Dates
The next estimated earnings date is Friday, August 8, 2025.
| Earnings Date | Aug 8, 2025 |
| Ex-Dividend Date | Feb 7, 2025 |
Share Statistics
NSE:GRSE has 114.55 million shares outstanding. The number of shares has increased by 0.00% in one year.
| Current Share Class | 114.55M |
| Shares Outstanding | 114.55M |
| Shares Change (YoY) | +0.00% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 1.09% |
| Owned by Institutions (%) | 4.07% |
| Float | 27.96M |
Valuation Ratios
The trailing PE ratio is 57.01 and the forward PE ratio is 36.44.
| PE Ratio | 57.01 |
| Forward PE | 36.44 |
| PS Ratio | 5.92 |
| PB Ratio | 14.46 |
| P/TBV Ratio | 14.62 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 1,928.82 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 62.53, with an EV/FCF ratio of -511.82.
| EV / Earnings | 49.95 |
| EV / Sales | 5.19 |
| EV / EBITDA | 62.53 |
| EV / EBIT | 69.55 |
| EV / FCF | -511.82 |
Financial Position
The company has a current ratio of 1.17, with a Debt / Equity ratio of 0.00.
| Current Ratio | 1.17 |
| Quick Ratio | 0.49 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.02 |
| Debt / FCF | -0.19 |
| Interest Coverage | 36.69 |
Financial Efficiency
Return on equity (ROE) is 28.11% and return on invested capital (ROIC) is 12.37%.
| Return on Equity (ROE) | 28.11% |
| Return on Assets (ROA) | 2.30% |
| Return on Invested Capital (ROIC) | 12.37% |
| Return on Capital Employed (ROCE) | 17.18% |
| Revenue Per Employee | 32.27M |
| Profits Per Employee | 3.35M |
| Employee Count | 1,573 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 1.11 |
Taxes
In the past 12 months, NSE:GRSE has paid 1.76 billion in taxes.
| Income Tax | 1.76B |
| Effective Tax Rate | 25.01% |
Stock Price Statistics
The stock price has increased by +13.90% in the last 52 weeks. The beta is 0.15, so NSE:GRSE's price volatility has been lower than the market average.
| Beta (5Y) | 0.15 |
| 52-Week Price Change | +13.90% |
| 50-Day Moving Average | 2,919.21 |
| 200-Day Moving Average | 1,958.99 |
| Relative Strength Index (RSI) | 47.20 |
| Average Volume (20 Days) | 906,117 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:GRSE had revenue of INR 50.76 billion and earned 5.27 billion in profits. Earnings per share was 46.04.
| Revenue | 50.76B |
| Gross Profit | 9.09B |
| Operating Income | 3.79B |
| Pretax Income | 7.03B |
| Net Income | 5.27B |
| EBITDA | 4.21B |
| EBIT | 3.79B |
| Earnings Per Share (EPS) | 46.04 |
Balance Sheet
The company has 37.32 billion in cash and 96.69 million in debt, giving a net cash position of 37.22 billion or 324.93 per share.
| Cash & Cash Equivalents | 37.32B |
| Total Debt | 96.69M |
| Net Cash | 37.22B |
| Net Cash Per Share | 324.93 |
| Equity (Book Value) | 20.79B |
| Book Value Per Share | 181.49 |
| Working Capital | 13.75B |
Cash Flow
In the last 12 months, operating cash flow was 155.87 million and capital expenditures -670.57 million, giving a free cash flow of -514.69 million.
| Operating Cash Flow | 155.87M |
| Capital Expenditures | -670.57M |
| Free Cash Flow | -514.69M |
| FCF Per Share | -4.49 |
Margins
Gross margin is 17.90%, with operating and profit margins of 7.46% and 10.39%.
| Gross Margin | 17.90% |
| Operating Margin | 7.46% |
| Pretax Margin | 13.86% |
| Profit Margin | 10.39% |
| EBITDA Margin | 8.30% |
| EBIT Margin | 7.46% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 13.85, which amounts to a dividend yield of 0.53%.
| Dividend Per Share | 13.85 |
| Dividend Yield | 0.53% |
| Dividend Growth (YoY) | 20.53% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 22.57% |
| Buyback Yield | -0.00% |
| Shareholder Yield | 0.54% |
| Earnings Yield | 1.75% |
| FCF Yield | -0.17% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |